ICCC
ICCC
NASDAQ · Biotechnology

Immucell Corp

$10.52
+0.30 (+2.94%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target -59.4% upside
Low Target $3.74
Average Target $4.27
High Target $6.64
Current Price $10.52
Current
$10.52
Target
$4.27
$3.74 $4.27 avg $6.64
Scenario Analysis
Bear Case
$3.74
-64.4%
Low target
Base Case
$4.27
-59.4%
Avg target
Bull Case
$6.64
+-36.9%
High target
Risk/Reward
0.6x
Unfavorable
Price in Context
52-Week High
$12.10
-13.1% from high
52-Week Low
$4.52
+132.7% from low
Target vs 52W High
$4.27
-64.7% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 -12.5%
AMGN
Amgen Inc
Hold 42 43% $190.87 -59.0%
GILD
Gilead Sciences Inc
Strong Buy 36 83% $362.68 +115.4%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -18.5%
MRNA
Moderna Inc
Hold 31 32% $149.45 -35.4%
REGN
Regeneron Pharmaceuticals
Buy 36 72% $76.80 -91.9%
NTRA
Natera Inc
Strong Buy 31 90% $142.91 -55.7%
RVMD
Revolution Medicines Inc
Strong Buy 31 94% $114.11 -35.3%